QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
PFE   53.73 (+2.54%)
AMC   33.94 (-7.87%)
BA   197.85 (-0.33%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
PFE   53.73 (+2.54%)
AMC   33.94 (-7.87%)
BA   197.85 (-0.33%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
PFE   53.73 (+2.54%)
AMC   33.94 (-7.87%)
BA   197.85 (-0.33%)
QQQ   393.82 (-1.47%)
AAPL   165.30 (+3.16%)
MSFT   330.59 (-1.79%)
FB   324.46 (-4.01%)
GOOGL   2,837.95 (-2.50%)
AMZN   3,507.07 (-1.53%)
TSLA   1,144.76 (+0.68%)
NVDA   326.76 (-2.10%)
BABA   127.53 (-3.10%)
NIO   39.13 (-3.29%)
CGC   10.71 (-3.16%)
AMD   158.37 (-2.19%)
GE   94.99 (-3.47%)
MU   84.00 (-2.48%)
T   22.83 (-4.44%)
F   19.19 (-2.44%)
DIS   144.90 (-1.97%)
ACB   6.42 (-0.31%)
PFE   53.73 (+2.54%)
AMC   33.94 (-7.87%)
BA   197.85 (-0.33%)
NASDAQ:FGEN

FibroGen SEC Filings & 10K Form

$12.51
+0.49 (+4.08%)
(As of 11/30/2021 04:00 PM ET)
Add
Compare
Today's Range
$11.75
$12.53
50-Day Range
$9.93
$13.15
52-Week Range
$9.88
$57.21
Volume
1.02 million shs
Average Volume
1.30 million shs
Market Capitalization
$1.16 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.96

FibroGen (NASDAQ:FGEN) SEC Filings

DateFilerForm TypeView
09/09/2021
8:35 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2021
8:33 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2021
8:32 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2021
8:30 PM
FibroGen (Issuer)
Graham Juan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/30/2021
7:11 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2021
3:31 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2021
7:30 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2021
9:33 AM
FibroGen (Subject)
FMR LLC (Filed by)
Form SC 13G/A
08/09/2021
4:28 PM
FibroGen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/08/2021
7:31 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2021
4:26 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2021
6:27 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
8:25 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
3:16 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2021
6:29 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
6:26 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
6:09 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
6:08 PM
FibroGen (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
6:07 PM
FibroGen (Issuer)
Lema Gerald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
6:07 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
6:06 PM
FibroGen (Issuer)
KEARNS THOMAS F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
6:05 PM
FibroGen (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
6:05 PM
FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
6:04 PM
EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
6:02 PM
Cravatt Benjamin (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
6:01 PM
Brennan Aoife (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
6:00 PM
Blaug Suzanne (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
3:07 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2021
3:22 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2021
7:30 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2021
3:59 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2021
5:22 PM
FibroGen (Issuer)
KEARNS THOMAS F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2021
4:38 PM
FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2021
4:34 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2021
4:32 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
3:18 PM
FibroGen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2021
6:28 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2021
6:25 PM
FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2021
6:23 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2021
6:21 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2021
6:19 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2021
6:07 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 3/A
02/19/2021
6:10 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2021
6:24 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
7:02 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
6:40 PM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
9:04 AM
FibroGen (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G/A
01/06/2021
6:08 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
5:07 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
4:10 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2020
6:06 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
6:04 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
6:34 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
6:33 PM
FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
6:30 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
6:27 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
5:51 PM
Eisner Mark (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2020
5:41 PM
Eisner Mark (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/01/2020
7:05 AM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2020
3:52 PM
FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
3:45 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
3:13 PM
FibroGen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/18/2020
4:19 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2020
12:19 PM
FibroGen (Filer)
Form CT ORDER
09/17/2020
5:03 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
6:36 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
6:32 PM
FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
6:30 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
6:28 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2020
3:33 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2020
3:30 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2020
4:58 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
3:34 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:50 PM
Cravatt Benjamin (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:45 PM
Brennan Aoife (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:29 PM
Cravatt Benjamin (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2020
6:25 PM
Brennan Aoife (Reporting)
FibroGen (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2020
3:16 PM
FibroGen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2020
3:10 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
3:06 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2020
6:33 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
7:51 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
7:47 PM
FibroGen (Issuer)
Wettig Thane (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/23/2020
3:59 PM
FibroGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2020
5:35 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2020
5:59 AM
Conterno Enrique A (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
8:22 PM
FibroGen (Issuer)
Rosenkranz Roberto Pedro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
6:48 PM
Chung Christine (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
6:47 PM
Cotroneo Pat (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
6:46 PM
FibroGen (Issuer)
Yu K Peony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2020
6:45 PM
FibroGen (Issuer)
Kouchakji Elias (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:34 PM
FibroGen (Issuer)
Schoeneck James A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:33 PM
FibroGen (Issuer)
Rosenkranz Roberto Pedro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:32 PM
FibroGen (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:31 PM
FibroGen (Issuer)
Lema Gerald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:30 PM
FibroGen (Issuer)
Kurkijarvi Kalevi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:28 PM
FibroGen (Issuer)
KEARNS THOMAS F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:27 PM
FibroGen (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:26 PM
FibroGen (Issuer)
Henderson Jeffrey William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
7:25 PM
EDWARDS JEFFREY L (Reporting)
FibroGen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.